ICON PLC (ICLR) Stock Fundamental Analysis
NASDAQ:ICLR - Nasdaq - IE0005711209 - Common Stock - Currency: USD
Overall ICLR gets a fundamental rating of 5 out of 10. We evaluated ICLR against 55 industry peers in the Life Sciences Tools & Services industry. ICLR has an average financial health and profitability rating. ICLR is valued quite cheap, while showing a decent growth score. This is a good combination! This makes ICLR very considerable for value investing!
1. Profitability
1.1 Basic Checks
ICLR had positive earnings in the past year.
ICLR had a positive operating cash flow in the past year.
In the past 5 years ICLR has always been profitable.
In the past 5 years ICLR always reported a positive cash flow from operatings.
1.2 Ratios
ICLR has a better Return On Assets (4.53%) than 76.36% of its industry peers.
ICLR has a Return On Equity of 7.98%. This is amongst the best in the industry. ICLR outperforms 81.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.71%, ICLR is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
ICLR had an Average Return On Invested Capital over the past 3 years of 5.80%. This is significantly below the industry average of 13.60%.
The last Return On Invested Capital (6.71%) for ICLR is above the 3 year average (5.80%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.53% | ||
| ROE | 7.98% | ||
| ROIC | 6.71% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
1.3 Margins
With a decent Profit Margin value of 9.25%, ICLR is doing good in the industry, outperforming 76.36% of the companies in the same industry.
ICLR's Profit Margin has declined in the last couple of years.
ICLR has a better Operating Margin (14.54%) than 76.36% of its industry peers.
In the last couple of years the Operating Margin of ICLR has remained more or less at the same level.
With a Gross Margin value of 29.06%, ICLR is not doing good in the industry: 74.55% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ICLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.54% | ||
| PM (TTM) | 9.25% | ||
| GM | 29.06% |
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICLR is destroying value.
The number of shares outstanding for ICLR has been reduced compared to 1 year ago.
The number of shares outstanding for ICLR has been increased compared to 5 years ago.
Compared to 1 year ago, ICLR has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.96 indicates that ICLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
ICLR's Altman-Z score of 1.96 is in line compared to the rest of the industry. ICLR outperforms 50.91% of its industry peers.
The Debt to FCF ratio of ICLR is 3.23, which is a good value as it means it would take ICLR, 3.23 years of fcf income to pay off all of its debts.
ICLR has a better Debt to FCF ratio (3.23) than 76.36% of its industry peers.
ICLR has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
ICLR has a Debt to Equity ratio (0.36) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 3.23 | ||
| Altman-Z | 1.96 |
ROIC/WACC0.84
WACC8.02%
2.3 Liquidity
A Current Ratio of 1.27 indicates that ICLR should not have too much problems paying its short term obligations.
ICLR has a worse Current ratio (1.27) than 80.00% of its industry peers.
ICLR has a Quick Ratio of 1.27. This is a normal value and indicates that ICLR is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.27, ICLR is doing worse than 72.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 2.85% over the past year.
Measured over the past years, ICLR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.23% on average per year.
Looking at the last year, ICLR shows a decrease in Revenue. The Revenue has decreased by -0.48% in the last year.
The Revenue has been growing by 24.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2.85%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-8.07%
Revenue 1Y (TTM)-0.48%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%-4.26%
3.2 Future
Based on estimates for the next years, ICLR will show a small growth in Earnings Per Share. The EPS will grow by 6.55% on average per year.
Based on estimates for the next years, ICLR will show a small growth in Revenue. The Revenue will grow by 2.07% on average per year.
EPS Next Y-3.13%
EPS Next 2Y2.25%
EPS Next 3Y4.6%
EPS Next 5Y6.55%
Revenue Next Year-3.76%
Revenue Next 2Y-0.87%
Revenue Next 3Y0.97%
Revenue Next 5Y2.07%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.85, the valuation of ICLR can be described as very reasonable.
Based on the Price/Earnings ratio, ICLR is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
ICLR is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.17, the valuation of ICLR can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 96.36% of the companies listed in the same industry.
ICLR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.70.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.85 | ||
| Fwd PE | 10.17 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 100.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ICLR indicates a rather cheap valuation: ICLR is cheaper than 98.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.18 | ||
| EV/EBITDA | 8.88 |
4.3 Compensation for Growth
The decent profitability rating of ICLR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.71
EPS Next 2Y2.25%
EPS Next 3Y4.6%
5. Dividend
5.1 Amount
ICLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
148.88
+3.43 (+2.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners101.17%
Inst Owner Change0.89%
Ins Owners0.63%
Ins Owner ChangeN/A
Market Cap11.83B
Analysts78.46
Price Target182.58 (22.64%)
Short Float %2.2%
Short Ratio1.07
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.48%
Min EPS beat(2)-1.19%
Max EPS beat(2)0.23%
EPS beat(4)1
Avg EPS beat(4)-3.85%
Min EPS beat(4)-14.41%
Max EPS beat(4)0.23%
EPS beat(8)1
Avg EPS beat(8)-2.42%
EPS beat(12)4
Avg EPS beat(12)-1.63%
EPS beat(16)7
Avg EPS beat(16)-0.69%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-2.61%
Max Revenue beat(2)-1.54%
Revenue beat(4)0
Avg Revenue beat(4)-3.45%
Min Revenue beat(4)-6.75%
Max Revenue beat(4)-1.54%
Revenue beat(8)0
Avg Revenue beat(8)-2.81%
Revenue beat(12)0
Avg Revenue beat(12)-2.47%
Revenue beat(16)0
Avg Revenue beat(16)-2.13%
PT rev (1m)-6.01%
PT rev (3m)-27.7%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)-4.01%
EPS NY rev (1m)0.13%
EPS NY rev (3m)-4.43%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-4.41%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)-4.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.85 | ||
| Fwd PE | 10.17 | ||
| P/S | 1.44 | ||
| P/FCF | 11.18 | ||
| P/OCF | 9.63 | ||
| P/B | 1.25 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.88 |
EPS(TTM)13.72
EY9.22%
EPS(NY)14.64
Fwd EY9.83%
FCF(TTM)13.31
FCFY8.94%
OCF(TTM)15.45
OCFY10.38%
SpS103.1
BVpS119.57
TBVpS-38.58
PEG (NY)N/A
PEG (5Y)0.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.53% | ||
| ROE | 7.98% | ||
| ROCE | 8.49% | ||
| ROIC | 6.71% | ||
| ROICexc | 6.97% | ||
| ROICexgc | 100.08% | ||
| OM | 14.54% | ||
| PM (TTM) | 9.25% | ||
| GM | 29.06% | ||
| FCFM | 12.91% |
ROA(3y)3.74%
ROA(5y)4.36%
ROE(3y)6.96%
ROE(5y)8.15%
ROIC(3y)5.8%
ROIC(5y)6.92%
ROICexc(3y)5.97%
ROICexc(5y)8.67%
ROICexgc(3y)88.82%
ROICexgc(5y)90.84%
ROCE(3y)7.34%
ROCE(5y)8.76%
ROICexcg growth 3Y-4.45%
ROICexcg growth 5Y-5.01%
ROICexc growth 3Y27.99%
ROICexc growth 5Y-24.17%
OM growth 3Y9.91%
OM growth 5Y-0.95%
PM growth 3Y50.65%
PM growth 5Y-6.44%
GM growth 3Y2.3%
GM growth 5Y-0.09%
F-Score7
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.36 | ||
| Debt/FCF | 3.23 | ||
| Debt/EBITDA | 2.08 | ||
| Cap/Depr | 39.01% | ||
| Cap/Sales | 2.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 75.48% | ||
| Profit Quality | 139.54% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.96 |
F-Score7
WACC8.02%
ROIC/WACC0.84
Cap/Depr(3y)27.79%
Cap/Depr(5y)38.09%
Cap/Sales(3y)1.87%
Cap/Sales(5y)1.83%
Profit Quality(3y)130.43%
Profit Quality(5y)205.36%
High Growth Momentum
Growth
EPS 1Y (TTM)2.85%
EPS 3Y13.76%
EPS 5Y15.23%
EPS Q2Q%-8.07%
EPS Next Y-3.13%
EPS Next 2Y2.25%
EPS Next 3Y4.6%
EPS Next 5Y6.55%
Revenue 1Y (TTM)-0.48%
Revenue growth 3Y14.75%
Revenue growth 5Y24.17%
Sales Q2Q%-4.26%
Revenue Next Year-3.76%
Revenue Next 2Y-0.87%
Revenue Next 3Y0.97%
Revenue Next 5Y2.07%
EBIT growth 1Y8.27%
EBIT growth 3Y26.12%
EBIT growth 5Y22.99%
EBIT Next Year1.89%
EBIT Next 3Y4.21%
EBIT Next 5Y4.16%
FCF growth 1Y191.78%
FCF growth 3Y15.01%
FCF growth 5Y25.32%
OCF growth 1Y139.85%
OCF growth 3Y15.78%
OCF growth 5Y25.55%